Albumin/Creatinine Ratio, As Predictor of Microalbuminuria, a Risk Factor For Nephropathy In Type 2 Diabetes Mellitus Patients.
Abdulrahaman A. Momin, Pankaja S Naik, G. M. Bhoite
Abstract
Abdulrahaman A. Momin, Pankaja S Naik, G. M. Bhoite
Abstract
Diabetic nephropathy is characterized by proteinuria and is the leading cause of end-stage renal disease worldwide. A case control study was designed to determine the prevalence of microalbuminuria in type 2 diabetic subjects. 50 subjects with type 2 diabetes and 50 normal healthy controls were screened for albumin and creatinine. The urinary albumin was calculated in terms of ratio with respect to urinary creatinine and expressed as albumin/creatinine ratio (mg/g). Albumin/Creatinine ratio in controls was found to be 11.05 ± 4.52 mg/g. The mean ± SD of Albumin/Creatinine ratio in total 50 patients was 38.77 ± 23.13 mg/g. The value of urinary albumin between 30 and 300 mg/g of creatinine was considered to be positive for microalbuminuria. Out of total 50 diabetic subjects, 31 patients were found to have albumin excretion of more than 30 mg/g of creatinine in random morning samples and therefore positive for microalbuminuria. The prevalence of microalbuminuria in type 2 diabetic subjects in this study was 62%. Use of the albumin-to-creatinine ratio in an untimed urinary sample should be recommended as the preferred screening strategy for all diabetic patients.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Diabetic nephropathy is characterized by proteinuria and is the leading cause of end-stage renal disease worldwide. A case control study was designed to determine the prevalence of microalbuminuria in type 2 diabetic subjects. 50 subjects with type 2 diabetes and 50 normal healthy controls were screened for albumin and creatinine. The urinary albumin was calculated in terms of ratio with respect to urinary creatinine and expressed as albumin/creatinine ratio (mg/g). Albumin/Creatinine ratio in controls was found to be 11.05 ± 4.52 mg/g. The mean ± SD of Albumin/Creatinine ratio in total 50 patients was 38.77 ± 23.13 mg/g. The value of urinary albumin between 30 and 300 mg/g of creatinine was considered to be positive for microalbuminuria. Out of total 50 diabetic subjects, 31 patients were found to have albumin excretion of more than 30 mg/g of creatinine in random morning samples and therefore positive for microalbuminuria. The prevalence of microalbuminuria in type 2 diabetic subjects in this study was 62%. Use of the albumin-to-creatinine ratio in an untimed urinary sample should be recommended as the preferred screening strategy for all diabetic patients.
Key concepts: Microalbuminuria, Medicine, Creatinine, Diabetic nephropathy, Internal medicine, Proteinuria, Diabetes mellitus, Urology